Bethany Samuelson Bannow, MD

Dr. Samuelson Bannow will begin her term as Editor in Chief of ASH Clinical News in January 2026, after serving as Deputy Editor and Associate Editor prior to that. She is a senior co-chair of the Thrombosis and Hemostasis Summit of North America biannual meeting for the 2024-2026 term. She also serves as a co-chair of the ASH Women in Hematology Committee, the Women and Thrombosis Committee in the VENUS (Venous thromboEmbolism Network US) network, and the Thrombosis Subcommittee in the Foundation for Women and Girls with Blood Disorders (FWGBD). She also serves on the Medical Advisory Committee for the FWGBD and the National Certification Board for Anticoagulation Providers and an Associate Editor for Research and Practice in Thrombosis and Haemostasis. She previously served as an Item Writer for the American Board of Internal Medicine Hematology board exam.

Dr. Samuelson Bannow completed a Masters in Clinical Research at OHSU in 2023. She completed the ASH Clinical Research Training Institute Program during the 2016-2017 academic year, the ASH Medical Educator's Institute during the 2017-2018 academic year and the ASH Advocacy Leadership Institute in 2024.

• 2007–present American College of Physicians
• 2013–present Hemostasis and Thrombosis Research Society
• 2014–present American Society of Hematology
• 2016–present International Society on Thrombosis and Haemostasis
• 2016–present VENUS Cancer-Associated Thrombosis Committee
• 2016–2024 ConECCTOR Junior Faculty Network, Co-chair (Apr 2017-Dec 2019)
• 2018-present VENUS Women and Thrombosis Committee
• 2018-present Foundation for Women and Girls with Blood Disorders
• 2021-present American Medical Women’s Association

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2025-10-06, Dr. Samuelson Bannow has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.